JP Morgan Chase & Co’s Oramed Pharmaceuticals ORMP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $449 | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $17.8K | Sell |
|
|||||
|
2024
Q1 | $32.7K | Sell |
|
|||||
|
2023
Q4 | $66.4K | Sell |
|
|||||
|
2023
Q3 | $120K | Sell |
|
|||||
|
2023
Q2 | $193K | Sell |
|
|||||
|
2023
Q1 | $379K | Sell |
|
|||||
|
2022
Q4 | $4.87M | Buy |
|
|||||
|
2022
Q3 | $1.84M | Sell |
|
|||||
|
2022
Q2 | $1.54M | Buy |
|
|||||
|
2022
Q1 | $153K | Sell |
|
|||||
|
2021
Q4 | $499K | Buy |
|
|||||
|
2021
Q3 | $246K | Buy |
|
|||||
|
2021
Q2 | $137K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $0 | Sell |
|
|||||
|
2020
Q1 | $9K | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $15K | Buy |
|
|||||
|
2017
Q3 | $9K | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $0 | Buy |
|